FERRANNINI, ELEUTERIO Statistiche

FERRANNINI, ELEUTERIO  

DIP. DI MEDICINA CLINICA E SPERIMENTALE - disattivato (attivo dal 19/09/2012 al 31/12/2019)  

Mostra records
Risultati 1 - 20 di 641 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autore(i) File
A comparative study of the in vitro antioxidant activity of statins 1-gen-2003 Franzoni, Ferdinando; Quinones Galvan, A; Regoli, F; Ferrannini, Eleuterio; Galetta, Fabio
A COMPARTMENTAL MODEL TO QUANTITATE INVIVO GLUCOSE-TRANSPORT IN THE HUMAN FOREARM 1-gen-1989 Cobelli, C; Saccomani, Mp; Ferrannini, Eleuterio; Defronzo, Ra; Gelfand, R; Bonadonna, R.
A MODEL OF GLUCOSE KINETICS AND THEIR CONTROL BY INSULIN, COMPARTMENTAL AND NONCOMPARTMENTAL APPROACHES 1-gen-1984 Cobelli, C; Toffolo, G; Ferrannini, Eleuterio
A novel surrogate index for hepatic insulin resistance 1-gen-2011 Vangipurapu, J; Stancakova, A; Kuulasmaa, T; Paananen, J; Kuusisto, J; Ferrannini, Eleuterio; Laakso, M.
A Phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes 1-gen-2013 Ferrannini, Eleuterio; Seman, L; Seewaldt Becker, E; Hantel, S; Pinnetti, S; Woerle, Hj
A strategy for arterial risk assessment and management in type 2 (non-insulin-dependent) diabetes mellitus 1-gen-1997 Dealmeida, Pp; Deleiva, A; Ericsson, A; Ferrannini, Eleuterio; Green, A; Home, Pd; Hemmann, D; Marshall, Sm; Standl, E; Vancrombrugge, P; Ykijarvinen, H.
A tale of two cousins: Type 1 and type 2 diabetes 1-gen-2005 Boitard, C; Efendic, S; Ferrannini, Eleuterio; Henquin, Jc; Steiner, Df; Cerasi, E.
Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus 1-gen-2013 Fonseca, Va; Ferrannini, Eleuterio; Wilding, Jp; Wilpshaar, W; Dhanjal, P; Ball, G; Klasen, S.
ACUTE ANTIHYPERGLYCEMIC MECHANISMS OF METFORMIN IN NIDDM - EVIDENCE FOR SUPPRESSION OF LIPID OXIDATION AND HEPATIC GLUCOSE-PRODUCTION 1-gen-1994 Perriello, G; Misericordia, P; Volpi, E; Santucci, A; Santucci, C; Ferrannini, Eleuterio; Ventura, Mm; Santeusanio, F; Brunetti, P; Bolli, Gb
ACUTE ELEVATION OF FREE FATTY-ACID LEVELS LEADS TO HEPATIC INSULIN RESISTANCE IN OBESE SUBJECTS 1-gen-1987 Bevilacqua, S; Bonadonna, R; Buzzigoli, G; Boni, C; Ciociaro, D; Maccari, F; Giorico, Ma; Ferrannini, Eleuterio
Acute insulin administration does not affect plasma leptin levels in lean or obese subjects 1-gen-1996 Muscelli, E; Camastra, Stefania; Masoni, A; Baldi, Simona; Sironi, Am; Natali, Andrea; Ferrannini, Eleuterio
ACUTE RESPIRATORY-DISTRESS SYNDROME IN AN ADULT PATIENT WITH A MYELODYSPLASTIC DISORDER 1-gen-1983 Pentimone, F; Cini, G; Meola, N; Ferrannini, Eleuterio
Acute vascular events and electrolytes variations in elderly patients 1-gen-2006 Solini, Anna; Zamboni, P; Passaro, A; Fellin, R; Ferrannini, Eleuterio
Adipocyte P2X(7) receptors expression: A role in modulating inflammatory response in subjects with metabolic syndrome? 1-gen-2011 Madec, S; Rossi, Chiara; Chiarugi, Massimo; Santini, E; Salvati, A; Ferrannini, Eleuterio; Solini, Anna
Adiponectin and left ventricular structure and function in healthy adults 1-gen-2008 Kozakova, M; Muscelli, E; Flyvbjerg, A; Frystyk, J; Morizzo, C; Palombo, Carlo; Ferrannini, Eleuterio
ADRENERGIC-BLOCKADE ALTERS GLUCOSE KINETICS DURING EXERCISE IN INSULIN-DEPENDENT DIABETICS 1-gen-1984 Simonson, Dc; Koivisto, V; Sherwin, Rs; Ferrannini, Eleuterio; Hendler, R; Juhlindannfelt, A; Defronzo, Ra
ADVANCE - Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline RID A-7832-2008 1-gen-2005 Chalmers, J; Macmahon, S; Cooper, M; Ferrannini, Eleuterio; Glasziou, P; Grobbee, D; Hamet, P; Harrap, S; Heller, S; Liu, Ls; Mancia, G; Marre, M; Mogensen, C; Neal, B; Pan, Cy; Patel, A; Poulter, N; Rodgers, A; Woodward, M; Collins, R; Holman, R; Sandercock, P; Sleight, P; Adams, M; Fulcher, G; Harrisberg, B; Mitchell, P; Pollock, C; Watson, J; Colman, S; Cormack, A; Flynn, S; Jayne, K; Joshi, R; Monaghan, H; Richens, A; Rodeghiero, C; Holloway, T; Gray, B; Milne, A; Adderkin, A; Bobbink, I; de Guise, D; Guertin, Mr; Ma, Ly; Reid, J; Stolk, R; Wen, W.
Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study 1-gen-2013 Solini, Anna; Penno, G; Bonora, E; Fondelli, C; Orsi, E; Trevisan, R; Vedovato, M; Cavalot, F; Cignarelli, M; Morano, S; Ferrannini, Eleuterio; Pugliese, G.
Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. 1-gen-2005 Antonelli, Alessandro; Rotondi, M; Fallahi, P; Romagnani, P; Ferrari, Sm; Ferrannini, Eleuterio; Serio, M.
Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis. 1-gen-2008 Antonelli, Alessandro; Ferri, C; Fallahi, P; Ferrari, Sm; Frascerra, S; Carpi, Angelo; Nicolini, Andrea; Ferrannini, Eleuterio